Literature DB >> 19387478

From the rarest to the most common: insights from progeroid syndromes into skin cancer and aging.

Brian C Capell1, Brook E Tlougan, Seth J Orlow.   

Abstract

Despite their rarity, diseases of premature aging, or "progeroid" syndromes, have provided important insights into basic mechanisms that may underlie cancer and normal aging. In this review, we highlight these recent developments in Hutchinson-Gilford progeria syndrome (HGPS), Werner syndrome, Bloom syndrome, Cockayne syndrome, trichothiodystrophy, ataxia-telangiectasia, Rothmund-Thomson syndrome, and xeroderma pigmentosum. Though they are caused by different mutations in various genes and often result in quite disparate phenotypes, deciphering the molecular bases of these conditions has served to highlight their underlying basic similarities. Studies of progeroid syndromes, particularly HGPS, the most dramatic form of premature aging, have contributed to our knowledge of fundamental processes of importance to skin biology, including DNA transcription, replication, and repair, genome instability, cellular senescence, and stem-cell differentiation.

Entities:  

Mesh:

Year:  2009        PMID: 19387478     DOI: 10.1038/jid.2009.103

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  16 in total

Review 1.  [Experimental models of human skin aging].

Authors:  G Nikolakis; C Zoschke; E Makrantonaki; C Hausmann; M Schäfer-Korting; C C Zouboulis
Journal:  Hautarzt       Date:  2016-02       Impact factor: 0.751

2.  Werner's syndrome may be lost in the shadow of the scleroderma.

Authors:  Emel Gonullu; Nazife Sule Yaşar Bilge; Timuçin Kaşifoğlu; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2012-11-06       Impact factor: 2.631

Review 3.  Oxidative and energy metabolism as potential clues for clinical heterogeneity in nucleotide excision repair disorders.

Authors:  Mohsen Hosseini; Khaled Ezzedine; Alain Taieb; Hamid R Rezvani
Journal:  J Invest Dermatol       Date:  2014-10-09       Impact factor: 8.551

Review 4.  Skin microbiota-host interactions.

Authors:  Y Erin Chen; Michael A Fischbach; Yasmine Belkaid
Journal:  Nature       Date:  2018-01-24       Impact factor: 49.962

5.  Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency.

Authors:  Alan F Rope; Kai Wang; Rune Evjenth; Jinchuan Xing; Jennifer J Johnston; Jeffrey J Swensen; W Evan Johnson; Barry Moore; Chad D Huff; Lynne M Bird; John C Carey; John M Opitz; Cathy A Stevens; Tao Jiang; Christa Schank; Heidi Deborah Fain; Reid Robison; Brian Dalley; Steven Chin; Sarah T South; Theodore J Pysher; Lynn B Jorde; Hakon Hakonarson; Johan R Lillehaug; Leslie G Biesecker; Mark Yandell; Thomas Arnesen; Gholson J Lyon
Journal:  Am J Hum Genet       Date:  2011-06-23       Impact factor: 11.025

6.  Premature skin aging features rescued by inhibition of NADPH oxidase activity in XPC-deficient mice.

Authors:  Mohsen Hosseini; Walid Mahfouf; Martin Serrano-Sanchez; Houssam Raad; Ghida Harfouche; Marc Bonneu; Stephane Claverol; Frederic Mazurier; Rodrigue Rossignol; Alain Taieb; Hamid Reza Rezvani
Journal:  J Invest Dermatol       Date:  2014-12-01       Impact factor: 8.551

7.  On the traces of XPD: cell cycle matters - untangling the genotype-phenotype relationship of XPD mutations.

Authors:  Elisabetta Cameroni; Karin Stettler; Beat Suter
Journal:  Cell Div       Date:  2010-09-15       Impact factor: 5.130

Review 8.  Human variation databases.

Authors:  Jan Küntzer; Daniela Eggle; Stefan Klostermann; Helmut Burtscher
Journal:  Database (Oxford)       Date:  2010-07-17       Impact factor: 3.451

Review 9.  [Epidermal aging and anti-aging strategies].

Authors:  J Wohlrab; K Hilpert; L Wolff
Journal:  Hautarzt       Date:  2016-02       Impact factor: 0.751

10.  Effect of GSTM1 polymorphism on risks of basal cell carcinoma and squamous cell carcinoma: a meta-analysis.

Authors:  Hao Peng; Quanyong He; Jie Zhu; Cheng Peng
Journal:  Tumour Biol       Date:  2012-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.